<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00550745</url>
  </required_header>
  <id_info>
    <org_study_id>V211-020</org_study_id>
    <secondary_id>2007_606</secondary_id>
    <nct_id>NCT00550745</nct_id>
  </id_info>
  <brief_title>ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)</brief_title>
  <official_title>A Phase IV Clinical Trial to Evaluate the Safety and Tolerability of ZOSTAVAX™ in Subjects ≥ 60 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the general safety of ZOSTAVAX™ in subjects 60 years
      of age or older as required by the FDA.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serious Adverse Events Reported Within 42 Days Postvaccination</measure>
    <time_frame>42 Days</time_frame>
    <description>Only Serious Adverse Events were collected and analyzed for this
study.
A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serious Adverse Events Reported Within 6 Months (Day 1 to 182) Postvaccination</measure>
    <time_frame>6 months</time_frame>
    <description>Only Serious Adverse Events were collected and analyzed for this study.
A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11999</enrollment>
  <condition>Herpes Zoster</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 1: vaccine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Arm 2: Placebo Comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Zoster Vaccine, Live</intervention_name>
    <description>single 0.65 mL Zoster Vaccine, Live injection. 6 month treatment period.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Comparator: placebo</intervention_name>
    <description>single 0.65 mL Placebo injection. 6 month treatment period.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60+ years of Age

          -  Signed an informed consent prior to the start of study

          -  Non-Feverish, (less than 101.0°F / 38.3°C) on day of vaccination

          -  Females must be postmenopausal or have a negative pregnancy test

        Exclusion Criteria:

          -  A history of allergic reaction to any vaccine component (including gelatin or
             neomycin)

          -  Prior receipt of any varicella or zoster vaccine

          -  Any live virus vaccine administered within 4 weeks before the start of the study or
             scheduled during the 42 days after vaccination

          -  Any inactivated virus vaccine, except for flu vaccine, administered within 7 days
             before the start of the study or scheduled during the 42 days after vaccination

          -  Subject is pregnant or breastfeeding

          -  Participation in an investigational drug or vaccine study within the last 30 days
             prior to the start of the study or expected during the 42 days after vaccination

          -  An ongoing illness (including active untreated tuberculosis) that might interfere with
             or prevent the subject from completion of the study

          -  Use of immunosuppressive therapy. Subjects taking corticosteroids such as prednisone
             should be excluded. Excluded immunosuppressive therapies also include chemotherapeutic
             agents used to treat cancer or other conditions, and treatments associated with organ
             or bone marrow transplantation

          -  Known or suspected immune dysfunction that is caused by a medical condition or any
             other cause. Examples of medical conditions associated with immune dysfunction include
             congenital immunodeficiency, human immunodeficiency virus (HIV) infection, organ or
             bone marrow transplantation, leukemia, lymphoma, Hodgkin's disease, multiple myeloma,
             or generalized malignancy. Subjects with a history of cancer who are not on active
             treatment and are not thought to have a weakened immune system at the time of
             enrollment will be eligible

          -  Any active use of non-topical antiviral therapy including but not limited to
             acyclovir, famciclovir, valacyclovir, ganciclovir, foscarnet, brivudine, and cidofovir
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Murray AV, Reisinger KS, Kerzner B, Stek JE, Sausser TA, Xu J, Wang WW, Chan IS, Annunziato PW, Parrino J. Safety and tolerability of zoster vaccine in adults ≥60 years old. Hum Vaccin. 2011 Nov;7(11):1130-6. doi: 10.4161/hv.7.11.17982. Epub 2011 Nov 1.</citation>
    <PMID>22048110</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2007</study_first_submitted>
  <study_first_submitted_qc>October 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2007</study_first_posted>
  <results_first_submitted>January 7, 2010</results_first_submitted>
  <results_first_submitted_qc>January 7, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 2, 2010</results_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>http://www.merck.com/clinical-trials/pdf/Merck%20Procedure%20on%20Clinical%20Trial%20Data%20Access%20Final_Updated%20July_9_2014.pdf
http://engagezone.msd.com/ds_documentation.php</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Phase IV
First subject enrolled on 17-Sep-2007.
Last subject enrolled on 19-Jun-2008.
The last subject's last visit was 15-Jan-2009.
The study was conducted at 46 study centers throughout the United States, Canada, Germany,
Spain, and United Kingdom.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>ZOSTAVAX™</title>
          <description>Represents the number of randomized subjects according to the vaccination group as they were assigned at study entry and not the treatment, ZOSTAVAX™ or placebo, received.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Represents the number of randomized subjects according to the vaccination group as they were assigned at study entry and not the treatment, ZOSTAVAX™ or placebo, received.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6000"/>
                <participants group_id="P2" count="5999"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5913"/>
                <participants group_id="P2" count="5939"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="87"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="45"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Screen failure</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ZOSTAVAX™</title>
          <description>Represents the number of subjects according to the treatment (ZOSTAVAX™) received.
Excludes subjects who were not vaccinated.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Represents the number of subjects according to the treatment (placebo) received.
Excludes subjects who were not vaccinated.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5983"/>
            <count group_id="B2" value="5997"/>
            <count group_id="B3" value="11980"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70.5" spread="7.5"/>
                    <measurement group_id="B2" value="70.4" spread="7.6"/>
                    <measurement group_id="B3" value="70.5" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <description>Age Group (years)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>60 to 69 Years of Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3092"/>
                    <measurement group_id="B2" value="3113"/>
                    <measurement group_id="B3" value="6205"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>70 to 79 Years of Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1994"/>
                    <measurement group_id="B2" value="1986"/>
                    <measurement group_id="B3" value="3980"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>≥ 80 Years of Age</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="897"/>
                    <measurement group_id="B2" value="898"/>
                    <measurement group_id="B3" value="1795"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3515"/>
                    <measurement group_id="B2" value="3525"/>
                    <measurement group_id="B3" value="7040"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2468"/>
                    <measurement group_id="B2" value="2472"/>
                    <measurement group_id="B3" value="4940"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="109"/>
                    <measurement group_id="B2" value="85"/>
                    <measurement group_id="B3" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5759"/>
                    <measurement group_id="B2" value="5770"/>
                    <measurement group_id="B3" value="11529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="115"/>
                    <measurement group_id="B2" value="142"/>
                    <measurement group_id="B3" value="257"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>U.S.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5309"/>
                    <measurement group_id="B2" value="5312"/>
                    <measurement group_id="B3" value="10621"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-U.S.</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="674"/>
                    <measurement group_id="B2" value="685"/>
                    <measurement group_id="B3" value="1359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of Residence</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Assisted Living</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="176"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="338"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Independent Residential</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5790"/>
                    <measurement group_id="B2" value="5821"/>
                    <measurement group_id="B3" value="11611"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nursing Home</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Serious Adverse Events Reported Within 42 Days Postvaccination</title>
        <description>Only Serious Adverse Events were collected and analyzed for this
study.
A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
        <time_frame>42 Days</time_frame>
        <population>All subjects who were vaccinated according to actual treatment received (ZOSTAVAX™ or placebo) and had safety follow-up.
Death - Number of subjects that had a fatal serious adverse event with an onset date within the 42 day reporting period. The date of death may have occurred after 42 days.</population>
        <group_list>
          <group group_id="O1">
            <title>ZOSTAVAX™</title>
            <description>All subjects who were vaccinated according to actual treatment received (ZOSTAVAX™) and had safety follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>All subjects who were vaccinated according to actual treatment received (Placebo) and had safety follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Serious Adverse Events Reported Within 42 Days Postvaccination</title>
          <description>Only Serious Adverse Events were collected and analyzed for this
study.
A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
          <population>All subjects who were vaccinated according to actual treatment received (ZOSTAVAX™ or placebo) and had safety follow-up.
Death - Number of subjects that had a fatal serious adverse event with an onset date within the 42 day reporting period. The date of death may have occurred after 42 days.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5979"/>
                <count group_id="O2" value="5990"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Serious Adverse Events (AEs)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                    <measurement group_id="O2" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious AEs deemed vaccine-related by investigator</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.26</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.91</ci_lower_limit>
            <ci_upper_limit>1.73</ci_upper_limit>
            <estimate_desc>Relative risk (ZOSTAVAX™/placebo) of proportion of subjects reporting ≥ 1 serious AE through 42 Days postvaccination and 95% Confidence Interval were based on Miettinen and Nurminen [Comparative analysis of two rates. Stat Med 1985;4:213-26] method.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serious Adverse Events Reported Within 6 Months (Day 1 to 182) Postvaccination</title>
        <description>Only Serious Adverse Events were collected and analyzed for this study.
A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
        <time_frame>6 months</time_frame>
        <population>All subjects who were vaccinated according to actual treatment received (ZOSTAVAX™ or placebo) and had safety follow-up.
Death - Number of subjects that had a fatal serious adverse event with an onset date within the 182 day reporting period. The date of death may have occurred after 182 days.</population>
        <group_list>
          <group group_id="O1">
            <title>ZOSTAVAX™</title>
            <description>All subjects who were vaccinated according to actual treatment received (ZOSTAVAX™) and had safety follow-up.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>All subjects who were vaccinated according to actual treatment received (Placebo) and had safety follow-up.</description>
          </group>
        </group_list>
        <measure>
          <title>Serious Adverse Events Reported Within 6 Months (Day 1 to 182) Postvaccination</title>
          <description>Only Serious Adverse Events were collected and analyzed for this study.
A serious adverse event is any adverse event that results in death, is life threatening, results in a persistent or significant disability/incapacity, results in hospitalization or prolongs an existing hospitalization, is a congenital anomaly/birth defect, is a cancer, is an overdose, or is considered an &quot;other important medical event&quot; based on medical judgement.</description>
          <population>All subjects who were vaccinated according to actual treatment received (ZOSTAVAX™ or placebo) and had safety follow-up.
Death - Number of subjects that had a fatal serious adverse event with an onset date within the 182 day reporting period. The date of death may have occurred after 182 days.</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5979"/>
                <count group_id="O2" value="5990"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Serious AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="340"/>
                    <measurement group_id="O2" value="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Serious AEs deemed vaccine-related by investigator</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.98</ci_lower_limit>
            <ci_upper_limit>1.32</ci_upper_limit>
            <estimate_desc>Relative risk (ZOSTAVAX™/placebo) of proportion of subjects reporting ≥ 1 serious AE through 6 months postvaccination and 95% Confidence Interval were based on Miettinen and Nurminen [Comparative analysis of two rates. Stat Med 1985;4:213-26] method.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious AEs reported within 6 months (182 days) postvaccination. Only Serious adverse events were collected in this study. The &quot;Other Adverse Events&quot; table is not applicable for this study and shows &quot;0/0&quot; for &quot; participants affected/at risk&quot;</time_frame>
      <desc>Subjects were instructed to call the site immediately, at any time during the study, if they experienced a serious adverse event. Subjects were also called by study staff at 42 days, 4 months, and 6 months postvaccination, using a prespecified phone script, to determine if subjects had a previously unreported serious adverse event.</desc>
      <group_list>
        <group group_id="E1">
          <title>ZOSTAVAX™</title>
          <description>All subjects who were vaccinated according to actual treatment received (Zostavax™) and had safety follow-up.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>All subjects who were vaccinated according to actual treatment received (Placebo) and had safety follow-up.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="340" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="300" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy mediastinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Macrocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypertensive heart disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Mitral valve prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ventricular hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Wandering pacemaker</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hyperaldosteronism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Uveitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Abdominal mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Colonic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastrointestinal motility disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Inflammatory bowel disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adhesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Catheter related complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hernia obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bone abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Enterococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lemierre syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Meningitis aseptic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pleural infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pyothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Septic phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urinary tract infection enterococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Anastomotic complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Anastomotic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Dislocation of joint prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Eyeball rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Foreign body trauma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Fracture displacement</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gastrointestinal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Graft thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator malfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>In-stent coronary artery restenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Incision site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Tracheal injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Blood sodium decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arthrofibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cardiac myxoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Gammopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease stage IV</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Melanoma recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Mycosis fungoides</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Myeloma recurrence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Neurilemmoma benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oesophageal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ovarian cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ovarian low malignant potential tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Peritoneal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Rectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cerebellar infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Embolic stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Global amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lacunar infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Bipolar I disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Catatonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Dissociative identity disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypotonic urinary bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Thyroidectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Femoral arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Femoral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5990"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5979"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5990"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

